Physician

Neil Gonter, MD

According to 2025 Medicare claims, Neil Gonter, MD (NPI: 1760465579) practices rheumatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES OF NORTH JERSEY (NPI: 1699871442; TIN: 222322338) and primary practice location at 07666-3521. Gonter is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Gonter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 751 traditional Medicare patients, billed 196,889 HCPCS/CPT codes, and received $2,857,973 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,515 prescription claims across 605 beneficiaries totaling $3,431,617 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 21 records totaling $292. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,058,540 to $3,431,617. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,069	93,097	$1,696,395
2016	737	104,089	$2,068,663
2017	686	108,081	$2,234,555
2018	696	106,437	$2,338,762
2019	626	108,786	$2,699,366
2020	581	100,173	$2,900,748
2021	623	99,266	$2,298,882
2022	665	130,340	$2,472,647
2023	699	156,931	$2,672,887
2024	751	196,889	$2,857,973

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	416	2,588	$1,058,540
2016	493	2,946	$1,334,386
2017	462	2,877	$1,502,976
2018	470	2,791	$1,666,741
2019	485	3,103	$1,827,993
2020	456	2,964	$2,192,291
2021	504	3,004	$2,059,048
2022	537	3,417	$2,641,751
2023	579	3,536	$2,942,194
2024	605	3,515	$3,431,617

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	582	1,402	$102
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	440	693	$13
80048	Blood test, basic group of blood chemicals (calcium, total)	449	1,019	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	343	861	$5
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	344	871	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	89	2,968	$766,732
Humira(Cf) Pen	Adalimumab	85	2,672	$640,967
Enbrel	Etanercept	21	784	$211,786
Rituxan	Rituximab	11	1,042	$150,282
Remicade	Infliximab	15	791	$113,547

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$292	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Neil Gonter, MD?

Tedicare shows public-source Medicare data for Neil Gonter, MD (NPI 1760465579), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Neil Gonter, MD have ACO affiliation data?

Neil Gonter, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Neil Gonter, MD?

Neil Gonter, MD is linked to RHEUMATOLOGY ASSOCIATES OF NORTH JERSEY (billing NPI 1699871442) in the available physician profile data.

Does Neil Gonter, MD have Open Payments data?

Neil Gonter, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.